Finding the right psychiatric medication can take time because individuals may respond differently to the same treatment. One factor that influences these differences is how the body processes medications, which can partly depend on inherited genetic variations.
Pharmacogenetic testing for psychiatric medications examines specific genetic variations that may affect how the body metabolizes certain drugs. This information can help healthcare professionals understand differences in medication processing and make more informed prescribing decisions.
However, genetic testing cannot guarantee which medication will work best or predict whether someone will experience symptom improvement. Understanding its potential benefits and limitations can help individuals make informed decisions about psychiatric treatment.
What Is Pharmacogenetic Testing and How Does It Work?
Pharmacogenetic testing examines how variations in a person’s DNA may influence their response to particular medications. It primarily focuses on genes involved in drug metabolism, which refers to how the body processes and eliminates medications.
This approach is commonly discussed as pharmacogenomics in psychiatry, helping healthcare professionals understand why certain individuals may process the same medication differently.
Most tests involve collecting a saliva or blood sample. A laboratory analyzes selected genetic variations and prepares a report explaining how those findings may relate to specific medications.
Depending on the test, the report may provide information about:
- Genetic variations associated with drug-metabolizing enzymes.
- Whether certain medications may be processed faster or slower than expected.
- Gene-medication relationships supported by clinical evidence.
- Potential prescribing considerations for selected medications.
These tests examine specific genetic markers rather than providing a complete assessment of someone’s mental health or overall medication response.
How Do Genetic Variations Affect Psychiatric Medication Metabolism?
One of the most established applications of genetic testing for psychiatric medication involves understanding differences in drug metabolism.
The body uses enzymes to break down and process medications. Inherited genetic variations can influence how efficiently these enzymes function, potentially changing how quickly certain drugs are processed.
The Role of CYP Enzymes
The cytochrome P450 (CYP) enzyme family plays an important role in processing many medications, including several commonly prescribed psychiatric drugs.
Three genes frequently discussed in psychiatric testing include:
- CYP2D6: Influences the metabolism of medications such as paroxetine and venlafaxine.
- CYP2C19: Helps process medications such as citalopram and escitalopram.
- CYP2B6: Contributes to the metabolism of certain medications, including sertraline.
Variations in these genes can influence enzyme activity and affect how efficiently particular medications are processed.
Understanding Metabolizer Types
Genetic testing reports may classify individuals according to how efficiently specific enzymes function. Common categories include:
- Poor metabolizers: Have significantly reduced enzyme activity and may process certain medications more slowly.
- Intermediate metabolizers: Have lower-than-normal enzyme activity.
- Normal metabolizers: Have enzyme activity within the expected range.
- Rapid metabolizers: Process certain medications faster than normal.
- Ultrarapid metabolizers: Have increased enzyme activity for particular metabolic pathways.
These classifications apply to individual genes and do not describe how someone processes every medication.
The Clinical Pharmacogenetics Implementation Consortium (CPIC) publishes evidence-based guidelines explaining how specific genetic variations may influence medication prescribing.
Can Genetic Testing Help Guide Antidepressant Selection?
Antidepressant genetic testing is one of the most discussed applications of pharmacogenetic research because several commonly prescribed antidepressants are processed through enzymes influenced by inherited genetic variations.
For example, CYP2C19 variations may affect how the body processes citalopram and escitalopram. Similarly, CYP2D6 variations can influence the metabolism of paroxetine and venlafaxine.
The 2023 CPIC guideline provides recommendations involving CYP2D6, CYP2C19, and CYP2B6 for selected serotonin reuptake inhibitor antidepressants.
However, the usefulness of genetic information varies depending on the medication and the strength of available clinical evidence.
These findings do not establish which antidepressant will provide the greatest symptom improvement. Instead, they may help healthcare professionals understand how a particular medication is likely to be metabolized and whether changes to prescribing decisions should be considered.
For additional information, see the CPIC Clinical Guideline for Serotonin Reuptake Inhibitor Antidepressants (2023).
What Can Genetic Testing Actually Tell You?
The usefulness of genetic testing depends on the genes examined, the medication being considered, and the available clinical evidence.
When an established gene-medication relationship exists, test results may provide several insights:
- How Certain Medications May Be Processed
Genetic variations can influence drug-metabolizing enzymes. Testing may help identify whether someone is likely to process a particular medication more slowly or quickly than expected.
- Potential Differences in Medication Exposure
Changes in enzyme activity can influence the amount of certain medications present in the body. This information may help clinicians consider appropriate prescribing approaches.
- Medication-Specific Clinical Considerations
For selected medications, professional guidelines explain how genetic findings may inform prescribing decisions. A healthcare professional may consider an alternative medication or dosage adjustment when appropriate.
- Additional Information After Previous Treatment Difficulties
For individuals who have experienced unexpected medication effects or challenges with previous treatments, genetic information may offer another piece of clinical evidence. However, it cannot establish exactly why a previous medication failed or guarantee better results with another option.
Overall, genetic testing provides information about specific biological processes involved in medication metabolism. It cannot independently determine the most appropriate psychiatric treatment.
What Are the Limitations of Genetic Testing for Psychiatric Medications?
Understanding the limitations of genetic testing is essential because genetic reports may sometimes appear more conclusive than the available scientific evidence supports.
Several important limitations should be considered.
It Cannot Guarantee Which Medication Will Work
Genetic variations associated with medication metabolism do not necessarily predict whether someone will experience meaningful improvement in their mental health.
A person may have a genetic profile associated with typical medication processing and still experience limited benefits or unwanted side effects.
Medication response involves biological, psychological, and environmental influences that cannot be explained through a limited genetic test.
It Cannot Predict Every Aspect of Medication Response
Medication response involves more than the enzymes responsible for drug metabolism. Other biological processes, including drug targets and receptor activity, also influence how medications work.
Some genetic markers associated with these processes have not demonstrated sufficient evidence for routine clinical use.
For example, CPIC does not recommend using SLC6A4 and HTR2A genetic results to guide serotonin reuptake inhibitor prescribing because the available evidence is insufficient or inconsistent.
It Does Not Replace Professional Psychiatric Evaluation
A genetic report cannot independently establish a mental health diagnosis, determine the severity of a condition, or identify the most appropriate treatment.
Psychiatric prescribing requires consideration of symptoms, medical history, previous medication experiences, other medications, and individual treatment needs.
Other Factors Also Influence Medication Processing
Genetics is only one factor affecting medication response. Age, liver function, general health, other medications, and certain lifestyle factors may also influence how the body processes psychiatric drugs.
The U.S. Food and Drug Administration (FDA) has cautioned against relying on unverified genetic tests that make unsupported claims about predicting medication response.
Its Table of Pharmacogenetic Associations provides information about genetic associations included in FDA drug labeling. However, the inclusion of an association does not automatically mean testing is recommended or that it can predict treatment effectiveness.
How Should Genetic Test Results Be Used in Psychiatric Care?
Understanding pharmacogenetic results requires more than reading a metabolizer category or looking at medication rankings in a laboratory report.
Healthcare professionals need to determine whether the identified genetic variation has an established relationship with the medication being considered.
This involves reviewing:
- Which genes and genetic variations were included in the test.
- Whether reliable clinical evidence supports the gene-medication relationship.
- Whether professional guidelines provide recommendations for that medication.
- Whether other medications or medical conditions could influence drug metabolism.
- Whether the findings are relevant to the individual’s treatment needs.
For example, a report may identify a CYP2C19 variation associated with altered enzyme activity. Its clinical significance depends on the medication being considered and the evidence supporting that relationship.
This is why psychiatric medication and genetics should be considered together through professional clinical interpretation. Genetic reports provide additional information, but treatment decisions should never depend on laboratory results alone.
How Does Genetic Testing Fit Into Mental Health Treatment?
Genetic testing and mental health treatment can complement established psychiatric care when specific genetic findings have recognized clinical relevance.
A healthcare professional may consider pharmacogenetic information when prescribing a medication with a well-established gene-related metabolic pathway, particularly when the results could contribute to a clinical decision.
However, testing is not necessary for everyone receiving psychiatric medication. Its usefulness depends on individual circumstances, the medications involved, and whether the results are likely to provide meaningful information.
At Cordial Psychiatry, professional mental health services include psychiatric evaluations, therapy, and medication management for individuals experiencing conditions such as depression, anxiety, and PTSD. Medication decisions involve considering symptoms, treatment history, and overall clinical needs.
Genetic information, when available and clinically relevant, can serve as one additional source of information within this process.
For individuals seeking accessible virtual psychiatric care, telehealth psychiatry services provide an opportunity to connect with mental health professionals through online appointments.
Frequently Asked Questions
Frequently Asked Questions
1. What happens during a pharmacogenetic test?
Most pharmacogenetic tests involve providing a saliva or blood sample. A laboratory analyzes selected genetic variations and prepares a report showing how those variations may influence the processing of certain medications.
2. How long does it take to get pharmacogenetic test results?
The turnaround time depends on the laboratory and testing provider. Results may take several days or longer. Healthcare professionals can review the report once it becomes available and determine whether the findings are relevant to current treatment.
3. Can pharmacogenetic testing be useful if I take multiple medications?
It may provide additional information about how genetic variations influence the metabolism of certain medications. However, healthcare professionals must also consider potential drug interactions, existing prescriptions, and other medical factors when interpreting the results.
4. Should I discuss genetic testing with my psychiatrist before ordering it?
Yes. Discussing testing with a psychiatrist beforehand can help determine whether it is appropriate for your circumstances, which medications may have clinically relevant genetic associations, and how the results could inform treatment decisions.
Conclusion
Genetic testing can provide useful insights into how the body processes certain psychiatric medications, but it cannot predict every treatment outcome. Its results are most valuable when interpreted alongside professional psychiatric evaluation, medical history, and individual treatment needs. Informed clinical decisions remain essential for safe and effective mental health care.

